Healthcare News and Research

Latest Healthcare News and Research

Health Gorilla announces launch of expanded physician portal

Health Gorilla today announced the launch of its expanded physician portal, part of a new clinical network the company will unveil next month to connect doctors, vendors, and patients within a single, secure platform.

13 Aug 2015

Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

Proxsys Rx, the nation's largest Integrated Outpatient Pharmacy Provider (IOPP), now provides an end-to-end solution to hospitals to help them comply with all aspects of the 340B program. Under the federally mandated 340B program, drug makers must provide eligible organizations with certain prescription drugs at significantly reduced prices.

13 Aug 2015

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

BioDelivery Sciences International, Inc. announced the approval by the U.S. Food and Drug Administration of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant.

13 Aug 2015

USciences professor provides infection control measures for college-bound students

Thousands of students across Greater Philadelphia will soon start the next chapter of their lives as they begin their college journeys away from home.

13 Aug 2015

VTT develops miniature gas sensor for mobile devices to detect internal air problems

VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices. Gas measurements made with smartphones will make activities such as the detection of internal air problems easier. In addition, sleep quality will be measurable with greater precision, using mobile healthcare applications which gauge carbon dioxide quantities.

13 Aug 2015

USF Health, FORCE receive $1.45 million from PCORI to advance and expand clinical research network

A team led by the University of South Florida Morsani College of Medicine and the leading national hereditary breast and ovarian cancer advocacy organization, FORCE (Facing Our Risk of Cancer Empowered) received a $1.45-million funding award for a three-year project from the Patient-Centered Outcomes Research Institute to continue to advance and expand the ABOUT Network as part of the second phase of PCORnet: the National Patient-Centered Clinical Research Network.

13 Aug 2015

UNMCC receives NCI Comprehensive Cancer Center designation for cancer treatment, research programs

The University of New Mexico Cancer Center has been awarded the highest designation and rating in the United States for cancer treatment and research programs. It has received the National Cancer Institute's "NCI Comprehensive Cancer Center" designation, identifying it as one of the leading cancer centers in the nation and the only such cancer center in New Mexico.

13 Aug 2015

BIDMC researchers examine impact of note sharing on patient safety, quality of care

Researchers from Beth Israel Deaconess Medical Center are homing in on the potential benefits of allowing patients access to the notes their clinicians write after a visit. An article published in the August edition of The Joint Commission Journal on Quality and Patient Safety suggests that this kind of patient engagement has the power to improve safety and quality of care.

13 Aug 2015

Chances of survival due to chemotherapy significantly lower for older breast cancer patients

Chemotherapy prolongs life for older adults with most types of cancer, but for women over the age of 80 with breast cancer, the chances of survival due to chemotherapy are significantly lower, according to a study led by researchers from The University of Texas Health Science Center at Houston.

13 Aug 2015

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

Non-invasive diagnostic imaging can rule out coronary artery disease (CAD) in about 50% of women with atypical chest pain who are at relatively low risk for CAD, while exposing them to only a modest dose of radiation.

13 Aug 2015

Common marker can help identify patients at high risk for deadly cardiac events

A marker commonly used to determine if a patient is having a heart attack can also be used to identify stable patients at high risk for deadly cardiac events, according to a new study led by investigators at Brigham and Women's Hospital.

13 Aug 2015

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.

12 Aug 2015

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Lucideon is pleased to announce the acquisition of a second Dynamic Secondary Ion Mass Spectrometer (DSIMS). The investment doubles the capacity for DSIMS analysis at Lucideon and represents a response to the demand for the service and Lucideon’s commitment to satisfying customer requirements.

From Lucideon 12 Aug 2015

Dimension Data ranked 57th on 2015 Healthcare Informatics 100 list

Dimension Data, the $6.7 billion global ICT solutions and services provider, today announced that it ranked 57th on the 2015 Healthcare Informatics (HCI) 100 list. This year's ranking marks the third year in row Dimension Data has been included on the list.

12 Aug 2015

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced that it has entered into a license agreement with Advanced Dosage Forms, Inc. to expand Imprimis' proprietary ophthalmic injectable and combination topical compounded formulations into Canada. Under the agreement, the licensee has the rights to formulate, market and sell these formulations across Canada.

12 Aug 2015

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

The fledgling wearable devices market currently caters to a niche customer base. Improvements in devices and newer, interesting use cases will accelerate the transition to mass market proliferation. In addition to popular device manufacturers showcasing their wearable device ventures, an increasing number of industry-specific original equipment manufacturers are entering the market in partnership with technology companies.

12 Aug 2015

NEHEN selects Cognizant and TriZetto to manage technology infrastructure, improve efficiency and patient care

Cognizant today announced that the New England Healthcare Exchange Network, a consortium of regional payers and providers in the Northeast U.S., has selected Cognizant and its subsidiary TriZetto to digitally transform and manage its technology infrastructure to foster seamless collaboration across member organizations, optimize costs, and improve efficiency and patient care.

12 Aug 2015

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has closed the acquisition of additional ownership interest of The University of Texas MD Anderson Cancer Center Proton Therapy Center ("MD Anderson Proton Therapy Center").

12 Aug 2015

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Janssen Biotech, Inc., one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies.

12 Aug 2015

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

Scientists have identified a pathway that leads to the formation of atypical blood vessels that can cause blindness in people with age-related macular degeneration.

12 Aug 2015

Healthcare News and Research

Latest Healthcare News and Research

Health Gorilla announces launch of expanded physician portal

Proxsys Rx provides end-to-end solution to help hospitals comply with all 340B program

BDSI announces FDA approval of sNDA for new formulation of ONSOLIS (fentanyl buccal soluble film) CII

USciences professor provides infection control measures for college-bound students

VTT develops miniature gas sensor for mobile devices to detect internal air problems

USF Health, FORCE receive $1.45 million from PCORI to advance and expand clinical research network

UNMCC receives NCI Comprehensive Cancer Center designation for cancer treatment, research programs

BIDMC researchers examine impact of note sharing on patient safety, quality of care

Chances of survival due to chemotherapy significantly lower for older breast cancer patients

Non-invasive diagnostic imaging can rule out CAD in about 50% of women with atypical chest pain

Common marker can help identify patients at high risk for deadly cardiac events

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Lucideon acquires second Dynamic Secondary Ion Mass Spectrometer

Dimension Data ranked 57th on 2015 Healthcare Informatics 100 list

Imprimis, Advanced Dosage sign license agreement for proprietary compounded ophthalmic formulations

New Frost & Sullivan analysis finds that wearable devices to play large role in healthcare industry

NEHEN selects Cognizant and TriZetto to manage technology infrastructure, improve efficiency and patient care

Concord Medical closes acquisition of additional ownership interest in MD Anderson Proton Therapy Center

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Scientists identify molecular pathway that can contribute to vision loss in macular degeneration

Event guide: 3rd Measuring Patient Engagement Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Healthcare News and Research

Latest Healthcare News and Research

Event guide: 3rd Measuring Patient Engagement Summit eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in